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Purpose. Single-copy variants o f the autosomal recessive Star- 
gardt disease (STGl)l) gene ABCR (ABCA4) have been shown 
to confer enhanced susceptibility to age-related macular degen­
eration (AMD). To investigate the role o f  ABCR alleles in AMI) 
further, genotype-phenotype analysis was performed on sib­
lings o f patients with AMI) who had known ABCR variants. 
This genetically related population provides a cohort o f sub­
jects with similar age and ethnic background for genotype- 
phenotype comparison to the original probands.
Methods. All available siblings of 26 probands carrying proba­
ble disease-associated AHCK variants were examined clinically. 
Blood samples were collected from these siblings for genotype 
analysis to search for the ABCR variant alleles corresponding to 
the isofamilial proband.
Results. Nineteen o f 33 siblings from 15 families carried the 
respective proband’s variant AHCK allele. Some families exhib­
ited concordance of ABCR alleles with macular degeneration 
phenotype, but others did not. Exudative AMI) was uncommon 
among both probands and siblings.
Conclusions. Although population studies have indicated that 
some ABCR variant alleles may enhance susceptibility to AMI), 
investigation of the extent of ABCR involvement by kindred 
analysis is complicated by a plethora o f environmental and 
other hereditary factors not investigated in the current study
From the 'Department o f  Ophthalmology and Visual Sciences. 
Moran Bye Center. University o f  Utah School o f  Medicine. Salt Lake 
City. Utah: the ‘‘Department o f  Human Genetics. University o f Utah. 
Salt Lake City. Utah: the 'Laboratory o f Genomic Diversity. National 
Cancer Institute. Frederick Cancer Research and Development Center. 
Frederick. Maryland: the Departments o f 'Ophthalmology. ’ Pediatrics. 
‘’Medicine. Molecular and Human Genetics, and the sHuffington Cen­
ter on Aging. Baylor College o f  Medicine. Houston. Texas: the Depart­
ments o f ‘■’Ophthalmology and ' “Pathology. Columbia University. New 
York. New York: and the "Department o f Ophthalmology. Massachu­
setts Bye and Bar Infirmary. Harvard Medical School. Boston. Massa­
chusetts.
Supported by National Institutes o f  Health Grants EYI 1600 and 
EYI 1309: by Research to Prevent Blindness. Inc.. the Foundation 
Fighting Blindness (JMS. RAL. JRL. PSB. ML): and by the Steinbach 
Fund. New York. New York. DNA preparation and sequencing at the 
University o f  Utah were supported in part by core grants from the 
National Cancer Institute (5p30CA42014) and the National Center for 
Research Resources (M01-RR00064). RAL is a Research to Prevent 
Blindness Senior Scientific Investigator. JMS is a Lew R. Wassermann 
Merit Award recipient from Research to Prevent Blindness, and PSB is 
a Research to Prevent Blindness Sybil B. Harrington Scholar in macular 
degeneration research.
Submitted for publication May 23. 2001: revised September 17. 
2001: accepted October 23. 2001.
Commercial relationships policy: N.
The publication costs o f this article were defrayed in part by page 
charge payment. This article must therefore be marked ‘‘advertise­
m ent’  in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Paul S. Bernstein. Department o f  Ophthal­
mology and Visual Sciences. Moran Eye Center. University o f  Utah 
School' o f  Medicine. 50 North Medical Drive. Salt Lake City. UT 84132: 
paul.bernstein@hsc.utah.edu.
that may also play important roles. (Invest Ophthalmol Vis Sci. 
2002;43:466-473)
f I 1 lie ABCR (ABCA4) gene codes for a retina-specific protein 
A  on the rims of photoreceptor outer segment discs that 
appears to facilitate the transport o f retinoids during the visual 
cycle.1'2 Homozygous and compound heterozygous mutations 
in ABCR are responsible for recessive Stargardt macular dys­
trophy (STGD1),',-I° some cases o f recessive retinitis pigmen­
tosa, 11 and a substantial fraction o f autosomal recessive cone- 
rod dystrophies.l2Jil Because STGDl shares phenotypic 
similarities with age-related maculopathy (ARM) and age-re­
lated macular degeneration (AMD), we have screened previ­
ously for ABCR sequence variants in clinic populations with 
moderate to advanced nonexudative and disciform AMD. We 
reported that 16% o f an initial cadre of patients with AMD 
(26/167) had h etc rozygous A HCR variants that resulted in non­
conservative amino acid substitutions, frameshifts, or splice- 
site changes that were found in less than 1% o f a general 
population control cohort.11 Two variants, G 196IE and 
D2177N, accounted for half o f the reported disease-associated 
variants, whereas the others were rare variants found in one or 
two affected individuals.1"*
Two groups subsequently reported much lower rates of 
potential disease-associated ABCR variants in their cohorts of 
patients with AMD,15-17 but their selected populations, clinical 
criteria, and mutation detection rates differed substantially 
from the initial study.18 More recently, however, a large mul­
ticenter international consortium confirmed that G 1961E and 
D2177N variants o f ABCR are indeed found in patients with 
AMD at a significantly higher frequency relative to control 
subjects.19 The two variants were found in 3.4% of patients 
with AMI) (40/1 189) versus 0.95% of control subjects (12/ 
1258; P <  0.0001).19
We postulate that relatives o f patients with Stargardt 
disease and o f patients with AMD who are heterozygous 
carriers o f the same variant ABCR alleles as the family 
proband may have an increased risk o f development o f AMD 
under some circumstances. Several groups have reported 
pedigrees in which ABCR variants cosegregate with AMD in 
parents and grandparents o f STGD probands,20-22 but the 
number o f available families with two or three surviving 
generations has been limited. In this study we examined and 
genotyped all available siblings o f the subjects with disease- 
associated ABCR variants from our initial study o f ABCR in 
AMD,11 and we obtained additional information on the phe­
notype o f the family probands. Our goal was to determine 
the concordance o f mutant ABCR  alleles with the AMD 
phenotype in these families.
M a ie k ia i  s ajnd M e t h o d s
All subjects found to have AMD-associated ABCR variants from the 
initial study o f  ABCR in AMD1 ‘ were asked to provide contact infor­
mation for all living siblings. Available siblings were examined by one 
o f  the authors (PSB or JMS) or by the subject's personal ophthalmolo­
gist if the patient was unable to visit either Salt Lake City or Boston.
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T a ble  1 . AMD Diagnostic Criteria
Grade 1: no drusen or nonextensive small (hard) drusen. without 
pigment abnormalities 
Grade 2: extensive small (hard) drusen or pigment abnormalities 
2a: drusen
2b: RPE changes (hypo- or hyperpigmentation)
2c: both
Grade 3: extensive intermediate drusen or any large drusen 
3a: no drusenoid RPE detachment 
3b: drusenoid RPE detachment 
Grade 4: geographic atrophy 
Grade 5: exudative AMD 
5a: serous RPE detachment 
5b: CNVM or disciform scar
Drusen size: Small. < 6 3  fj.m ; intermediate. 6 3 - 1 2 5  /j.m ; large 
>  1 2 5  (im. CNVM. choroidal neovascular membrane.
Fundus photographs were then taken, and blood samples were ob­
tained for genotyping. This program complied with the policies o f the 
institutional review boards o f  the participating institutions and with 
the Declaration o f  Helsinki, and all subjects supplied provided in­
formed consent.
Grading o f fundus photographs was with the five-level scale 
for AMD classification used in previous studies (Table I ).23-24
Il is a modification o f  the scale used in the Age-Related Eye Disease 
Study (AREDS).2’  Fundus photographs were graded independently 
by the two clinical graders (PSR and JMS) lo assure consistency. 
Graders were unaware o f the subjects' clinical histories if the 
subjects did not originate from his or her site. Only rarely were the 
scores o f the graders discordant, and in these cases ( < 5 %  o f  pho­
tographs). the two graders reviewed these photographs together 
and achieved a consensus grade. When an individual’s right and left 
eyes had different grades, the higher grade was used for data 
analysis.
Sibling genotyping for the proband's ABCR mutation was per­
formed on samples o f peripheral blood by direct DNA sequencing with 
either o f two dye terminators (ART dRhodamine or Prism RigDye: PE 
Applied Riosystems. Foster City. CA) and cycle sequencing with DNA 
polymerase ( Taq FS: PE Applied Riosystems). DNA sequence was 
analyzed on an automated DNA sequencer (ART Prism 3 7 7 )  according
lo the manufacturer's protocols (PE Applied Riosystems). The sta­
tistic with the Cochran-Mantel-Haenszel option obtained odds ratios 
and 9 5 %  confidence intervals.
R esults
Genotype-Phenotype C haracterization  o f the 
O rig in a l C ohort o f Patien ts w ith  AMD
Family probands carrying probable disease-associated ABCR 
variants had been identified in our earlier report of the role of 
ABCR in AMD.1 J Before studying ABCR variants in their sib­
lings, we characterized the initial cohort of subjects in a sys­
tematic manner for trends in genotype-phenotype correlations 
that could be investigated further in these siblings. Fundus 
photographs from the 167 participants in the initial study were 
graded according to the system outlined as Table 1. The clinical 
phenotypes observed for specific ABCR alleles in the patients 
with AMD with disease-associated ABCR variants are in Table 2. 
Of the participants, 96.4% had moderate to advanced AMD 
(grades 3-5), whereas only 3.6% had early (borderline) age- 
related maculopathy (grade 2; Table 3). No subjects were 
unaffected (grade 1). Analysis of these data confirmed that 
possession of an ABCR variant was associated significantly with 
a dry nonexudative phenotype in subjects with moderate to 
advanced AMD, because the 95% confidence intervals for 
grades 3 and 4 compared with grade 5, although broad, did not 
overlap with 1.0. This result is important, because other stud­
ies in which investigators failed to find an association between 
ABCR variants and AMD enrolled much higher numbers of 
subjects with exudative (grade 5) AMD (>60% versus 26% in 
our initial study).151”
Further comparison of the initial study participants revealed 
the following characteristics, shown in Table 4: Subjects with 
ABCR variants had slightly earlier ages of AMD diagnosis rela­
tive to ,4/i0A'-ncgativc subjects, they were slightly more likely 
to be male, and they were more likely to have a self-reported 
family history o f AMD, although these differences were not 
statistically significant. Subjects with ABCR variants were more 
likely to have identical AMD grades in both eyes relative to 
,4/i0A'-ncgativc subjects—a result with borderline statistical 
significance, because the lower end o f the 95% confidence 
interval was 1.0.
Genotype-Phenotype C haracterization  o f S ib lings 
o f Subjects w ith  AM D V ariants
If an AMD family proband carries a heterozygous ABCR variant 
allele, each o f his or her siblings has a 50% chance of carrying 
the same ABCR variant. Because typically they are close in age
T able  2 .  AMD Grade of Probands Carrying Heterozygous ABCR Variants
ABCR Variant Grade 1 Grade 2 Grade 3 Grade 4 Grade 5
E471K 0 0 1 1 0
P940R* 0 0 0 1 0
T1428M 0 0 1 0 0
R1517S 0 0 0 1 0
11562T 0 0 1 1 0
G1578R 0 0 1 0 0
5196+1G—*A 0 0 1 0 0
R1898H 0 0 0 1 0
G1961E 0 0 2 4 0
L1970F 0 0 1 0 0
6519A1lbp 0 0 0 1 0
D2177N 0 1 3 3 0
6568AC 0 0 0 0 1
Data are number o f  probands al each grade.
* The patient reported lo have the R1129L ABCR variant in Table 1 o f the original study14 actually had 
Stargardt disease and should have been reported in the STGD column. Subsequent lo the publication of 
the initial study, one o f the original 167 patients was found lo have a P940R ABCR variant that was not 
present in the STGD or general-population cohorts.
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95%  C onfidence
Grade n % n % n % Odds Ratio Interval
2 1 3.8 5 3.5 6 3.6 8.6 0.5-159.8
3 11 42.3 45 31.9 56 33.5 10.5 1.3-84.9
4 13 50.0 48 34.0 61 36.5 11.6 1.5-92.8
5 1 3.8 43 30.5 44 26.3 1.0 —
Total 26 100 141 100 167 100
to the probands, are of the same ethnicity, and have usually 
shared the same environment for decades, siblings are a rea­
sonable population in which to study genotype-phenotype 
correlations of ABCR variants with AMD.26 We attempted to 
enroll and to examine all available siblings, whether or not they 
had a known history o f AMD. Self-reporting of a positive or 
negative history' o f AMD is notoriously inaccurate, especially 
because significant maculopathy (i.e., extensive druscn) can be 
compatible with normal visual acuity.lo'27 Among the fourteen 
Utah probands with ABCR variants, four had no living siblings 
and one declined to participate. The other nine Utah probands 
had a total of 27 living siblings, two of whom refused to 
participate. One other sibling was excluded due to the pres­
ence o f confounding macular disease (bilateral parafoveal tel­
angiectasis severe enough to have had laser treatment). Among 
the 12 Boston probands with ABCR variants, 2 had no siblings,
3 had no living siblings, and 1 declined to participate. The 
other six Boston probands had a total of nine living siblings, all 
o f whom were willing to participate. Thus, a total of 33 living 
siblings from 15 families were available for examination.
Nineteen o f these 33 siblings carried the family proband’s 
variant ABCR allele. Fundus photograph grading of all available 
siblings revealed that exudative AMD (grade 5) was found in 
only two siblings, one with an ABCR variant, and one without 
an ABCR variant (Fig. 1). Thirteen of 19 siblings with the 
proband’s variant had at least some signs o f AMD (grades 2-5), 
whereas 6 had normal maculae. Eight of 14 siblings without the 
proband’s variant had grades 2 to 5, presumably through a 
pathway not mediated by ABCR. Thus, siblings with the ABCR 
variant identical with the family proband were somewhat more 
likely to show signs of AMD when compared with the siblings
who did not carry the variant (odds ratio 1.63; 95% confidence 
interval, 0.39-6.82). As discussed in the following paragraph, 
a much larger number of subjects are needed for sufficient 
power to confirm this trend in a statistically significant manner.
Statistical analysis becomes even more challenging if indi­
vidual ABCR variants are examined, because the number of 
subjects becomes quite small, but two variants, G1961E and 
D2177N, deserve special attention. Not only are they more 
common than other AMD-associated variants,1-1 but their asso­
ciation with risk of AMD has been confirmed in a large con­
sortium study,19 and they altcr.1/ie /\’ adenosine triphosphatase 
(ATPase) activity in vitro in a manner similar to the majority of 
Stargardt- and AMD-associated ABCR variants analyzed so far.2S 
Three of four siblings of G1961E probands who also carried the 
variant G1961E allele had grade 2 or greater maculopathy, 
whereas both siblings who did not carry the variant allele had 
grade 4 disease. Four of seven siblings o f D2177N probands 
who also carried the variant allele had grade 2 or greater 
maculopathy, whereas four of five siblings who did not carry 
the variant D2177N allele had grade 2 or greater maculopathy. 
Similar difficulty in demonstrating gcnotypc-phcnotypc con­
cordance in AMD families with these two ABCR variants has 
been reported recently.29
Pedigree analysis of the kindreds showed various patterns 
o f association of the family proband’s ABCR variant with AMD 
phenotype of the siblings. For example, all three living siblings 
in kindred K4495 share the proband’s 11502T ABCR allele (Fig.
2), and all four had virtually identical severe bilateral geo­
graphic atrophy of the macula (grade 4 AMD) with onset late in 
the seventh or early in the eighth decade of life in each 
individual (Fig. 3). Kindred K4985, in contrast, shows no clear
T able  4 .  Characteristics o f  Initial Study Participants According lo Presence or Absence 










n % n % n % Ratio Interval
Age al diagnosis (y)
-=65 9 35 47 34 56 34 1.6 0.5-5.7
66-75 13 50 60 43 73 44 1.8 0.6-6.1
=*76 4 15 34 23 38 22 1.0 —
Gender
Female 17 65 98 70 115 69 0.8 0.3-2.0
Male 9 35 43 30 52 31 1.0 —
Family history o f  AMD
Yes 16 62 66 47 82 49 1.8 0.8-4.3
No 10 38 75 53 85 51 1.0 —
Grade o f  AMD in each eye*
Same 21 84 90 64 111 67 2.9 1.0-9.0
Different 4 16 50 36 54 33 1.0 —
* Two subjects had dense media opacities in the fellow eye.
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F ig u r e  1. Distribution o f AMD grade o f siblings according to pres­
ence or absence o f the proband's ABCR variant.
segregation of the family's D2177N ABCR allele with AMD 
phenotype (Fig. 4). The eldest sibling had moderate (grade 3) 
AMD, but did not carry the family proband's D2177N ABCR 
variant. Two siblings (one older and one younger than the 
proband) carried the D2177N variant and exhibited mild to 
moderate AMD, whereas two others (one older and one 
younger than the proband) carried the variant but exhibited no 
signs of AMD. It should be noted, however, that all members of 
this kindred were between 55 and 69 years old, and it is 
possible that AMD will develop in some of the unaffected 
siblings in future years, because the prevalence of AMD in­
creases substantially after age 70.3'"32 The other 13 Utah and 
Boston pedigrees are displayed in Figure 5.
D is c u ss io n
Age-related maculopathy and age-related macular degeneration 
are common traits that result from the complex interaction of 
environmental and hereditary risk factors. Some risk factors, 
such as cigarette smoking and increasing age, are well estab­
lished by multiple epidemiologic studies.3" ~32 Other risk fac­
tors such as nutrition and race are strongly suspected to play a 
role, along with gender, light exposure, and cardiovascular 
disease, for which the supporting data are more equivo­
cal.11 11 Genetic susceptibility to visual loss from AMD has 
long been suspected, especially because many patients note 
that AMD seems to “run in the family.” This notion is supported 
by an epidemiologic study that demonstrated an age-adjusted 
2.4-fold elevated relative risk o f AMD in first-degree relatives of
patients with AMD.27 Definitive demonstration of an inherited 
risk factor for AMD has been elusive, however. Human molec­
ular genetics has had by far the most success in defining the 
genetic etiology o f ophthalmic diseases with a clear mono­
genic hereditary basis and well-defined diagnostic criteria. Ge­
netic studies on retinitis pigmentosa,31 retinoblastoma,35 and 
color blindness36 are excellent examples of such successes. 
Determining genetic factors involved in late-onset common 
ophthalmic disorders with variable clinical presentations such 
as glaucoma and AMD has been a far more evanescent goal.
A cornerstone methodology for studying the genetics of 
human diseases is the collection and characterization of mul- 
tigenerational kindreds with the disorder. This approach is 
quite problematic for AMD, however. As a disease o f the 
elderly, the affected proband's parents are usually dead, sib­
lings are often dead or in widely scattered locations, and 
offspring are typically too young to manifest symptoms. Even 
with the ascertainment of a large kindred with AMD, the 
researcher is faced with substantial challenges, due to the high 
prevalence o f the disease, its variable expressivity, and its 
apparent multifactorial etiology. Unlike a relatively uncommon 
disease such as retinitis pigmentosa, in which affected family 
members almost certainly have identical genetic defects, the 
situation is not as simple for AMD. Interaction of multiple 
AMD-associated alleles in many genes may be needed for in­
creased susceptibility within a particular family. Thus, it cannot 
be assumed that affected siblings must have the same AMD- 
associated allele. The broad spectrum o f clinical presentation 
of AMD ranging from exudative changes to geographic atrophy 
raises the question of whether AMD is truly one disorder or 
actually represents a multitude o f diseases with different ge­
netic etiologies, and the variable presentation and progression 
of AMD often requires an arbitrary delineation o f which indi­
viduals are or are not affected. The interplay o f nongenetic risk 
factors for AMD, such as smoking history, nutritional status, 
and light exposure complicates genetic studies because even if 
an individual has inherited a putative AMD susceptibility allele, 
the disease may not manifest if a protective lifestyle has been 
practiced. Also, age must be considered a factor, because a few 
soft and hard drusen in the macula o f a 95-year-old patient may 
be normal, whereas the same findings in a 45-year-old patient 
may be considered the first signs of AMD.
Even if linkage is established to a chromosomal locus, it is 
often a long and arduous task to determine the actual genetic 
defect, because the chromosomal locus may encompass do/-
Figurf. 2. Pedigree of kindred K4495.
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F ig u r e  3. Fundus photographs from 
the family in Figure 2: (A) subject 
30610: (B) subject 25793 (proband): 
(C) subject 29038: (D) subject 29236.
ens o f genes. Significant linkage has been reported only re­
cently in one AMD family at locus 1 q25-31,37 and it is likely that 
further progress with this approach will continue to be slow. '* 
The genetic investigation o f AMD is amenable to the “can­
didate disease” approach. AMD shares phenotypic similarities 
to a number o f hereditary' diseases o f the macula, and as the 
genetic bases for these diseases are ascertained, cohorts of 
patients with AMD can then be screened to determine whether 
comparable mutations are involved in the pathogenesis of 
AMD."’ Stargardt disease (STGDl) is the most promising can­
didate disease for AMD. This autosomal recessive disorder is 
the most common early-onset macular dystrophy encountered 
in clinical practice (estimated frequency, 1 in 10,000).' It is 
characterized by macular atrophy and drusen-like flecks with 
associated central visual loss that typically occurs in the second 
or third decade o f life but with earlier and later onsets well 
documented. The retinal pigment epithelium (RPE) accumu­
lates large enough amounts of lipofuscin to exhibit a dark 
choroid on fluorescein angiography. Exudative complications 
are rare."’
If mutations in both alleles o f ABCR can lead to protein 
dysfunction severe enough to manifest as an early-onset mac­
ular dystrophy such as STGD1, is it possible that a mutation in 
one ABCR allele could lead to moderate dysfunction sufficient 
to cause latc-onsct macular degeneration such as AMD? Our 
findings of an elevated frequency of amino acid-changing 
ABCR variants in patients with AMD relative to age-matched 
control subjects supports this hypothesis.1' 19 Physiologically, 
this hypothesis is tenable. In patients with STGDl, severe 
ABCR dysfunction disrupts vitamin A transport pathways from 
the outer segment disks leading to formation of massive amounts 
of lipofuscin, which accumulates in the RPE. ’ Less profound 
disruption of ABCR function in the heterozygous state acting over 
a prolonged period could lead to a similar accumulation of 
lipofuscin, albeit at a much slower rate. Indeed, lipofuscin 
formation is strongly associated with the progression of 
AMD,39 '"  and knockout mouse studies have confirmed that 
both homozygous and heterozygous mutations in ABCR are 
associated with increasing lipofuscin accumulation over time, 
especially when these animals are exposed to light. "  "
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#31927 #32544 #33559
wild type D2177N D2177N
Grade 3 OD Grade 1 OD Grade 2 OD
Grade 3 OS Grade 1 OS Grade 3 OS
69 y.o. 67 y.o. 66 y.o.
#25988 #32020 #32178
D2177N D2177N D2177N
Grade 3 OD Grade 2 OD Grade 1 OD
Grade 3 OS Cataract OS Grade 1 OS
63 y.o. 58 y.o. 55 y.o.
F igure  4. Pedigree of kindred K4985.
Similarly, as has been demonstrated in other clinical disor­
ders associated with mutations in ABCR, this study was not and 
could not be designed to detect complex alleles that comprise 
a substantive fraction o f all ABCR mutations, especially be-
F ig u r e  5. Pedigrees o f 13 additional Utah (TC) and Boston (F) ABCR 
AMD kindreds. Arrows: family proband for each kindred. The pro­
band’s ABCR variant is listed below  each individual if il is present. WT, 
the sibling possesses the wild-type ABCR alleles, rather than the pro­
band’s variant. Filled symbols', grade 3 to 5 maculopathy present in al 
least one eye: striped symbols: borderline (grade 2) maculopathy: open 
symbols: no maculopathy in either eye (grade 1).
cause complete sequencing and segregation through at least 
two generations could not be performed. However, complex 
alleles probably play a greater role in both the structural and 
physiologic functions of ABCR than have been appreciated to 
date, and the consequences of a single complex mutation in 
the heterozygote over many decades are only now being in­
vestigated in detail.111
When we examined siblings of patients with AIJCR variants, 
we demonstrated concordance of ABCR genotype with AMD 
phenotype in some families, but not in others. Also, when the 
data from all the families were pooled, they did not show a 
statistically significant correlation between ABCR variants and 
risk of AMD, possibly in part because of the relatively small 
numbers of study participants. Some elderly siblings had an 
ABCR variant, but no evidence o f AMD. Other elderly siblings 
had AMD without having the same ABCR variant as the affected 
proband.
There are several possible explanations for the variable 
expressivity of AMD among those with ABCR variants. AMD 
progression in individuals with ABCR variants may be strongly 
influenced by concomitant environmental risk factors, such as 
smoking, light exposure, and diet, that were not examined or 
controlled in this study. Our study of the D2177N and G1961E 
mutations in age-matched ophthalmoscopically examined con­
trol subjects confirms that an ABCR variant does not by itself 
confer an AMD phenotype in all cases, but may increase sus­
ceptibility to the complex trait when large populations are 
examined.19
The fact that many siblings have AMD without the same 
ABCR variant as the family proband is not unexpected, espe­
cially because there are likely to be other inherited and envi­
ronmental risk factors that have not yet been identified that 
may act alone or in concert with ABCR alleles to enhance 
susceptibility to AMD. Depending on the age of the individual, 
the risk of having AMD can be quite substantial. If an individual 
is over age 70, he or she has a 30% risk of having AMD or
ARM. ' Also, we did not screen for other AIKJi mutations in
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the siblings beyond the known variant o f the proband. Thus, 
the contribution of other possible ABCR variants in these 
families is unknown. Because at least 4% o f the general popu­
lation is thought to carry' a mutant AHCR allele,518 this effect 
may be important.
The combined effects of variable expressivity at the age of 
surveillance and high disease prevalence made it unlikely that 
statistical significance could be achieved in a study of this size. 
This is a recurring problem facing investigators studying other 
complex adult-onset multifactorial diseases, such as breast can­
cer and prostate cancer.‘Mv*7 Statistical power analysis indi­
cates that we would need 144 siblings to achieve an 80% 
power o f detecting a statistically significant elevated risk at P  = 
0.05 if the study population prevalence o f AMD is assumed to 
be 10% and the elevated risk of AMD conferred by any AMD- 
associated ABCR variant is comparable to the approximately 
threefold elevation in AMD risk found for the G1961E and 
D2177N ABCR variants in the International AHCR Consortium 
Study.19
Although there is mounting evidence that heterozygous 
variants in ABCR contribute to AMD susceptibility, we should 
not expect consistent concordance o f variant alleles with AMD 
phenotype, because it is a complex trait influenced by a mul­
titude o f other hereditary and environmental risk factors. Nev­
ertheless, study of the families reported here has yielded im­
portant conclusions: (1) Affected siblings with the same ABCR 
variant may have highly concordant disease phenotypes. For 
example, all four siblings in kindred K4495 carried the same 
I1562T mutation, and all four had severe geographic atrophy in 
their eighth decade. (2) Exudative AMD, although present in 
more than 25% of the original study participants, was rare 
(<4% ) among family probands found to have ABCR variants. 
Similarly, exudative AMD was also found to be uncommon 
(1/19) in probands' siblings possessing the identical ABCR 
variant. This correlates well with fact that Stargardt disease is 
almost exclusively a nonexudative macular dystrophy.
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